DAFNA Capital Management’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $232K | Hold |
137,174
| – | – | 0.06% | 73 |
|
|
2025
Q1 | $280K | Hold |
137,174
| – | – | 0.08% | 78 |
|
|
2024
Q4 | $451K | Hold |
137,174
| – | – | 0.11% | 74 |
|
|
2024
Q3 | $377K | Hold |
137,174
| – | – | 0.09% | 75 |
|
|
2024
Q2 | $558K | Hold |
137,174
| – | – | 0.13% | 73 |
|
|
2024
Q1 | $918K | Buy |
+137,174
| New | +$918K | 0.21% | 62 |
|